Strimvelis 1-10 x 10e6 cells/mL dispersion for infusion
Authorisation EU/1/16/1097/001 · Fondazione Telethon Ets
- Licence holder
- Fondazione Telethon Ets (all products →)
- Active substance
- Autologous cd34+ enriched cell fraction
- Dosage form
- Dispersion for infusion
- Route of administration
- Intravenous use
- ATC code
- L03
- First authorised
- 26/05/2016
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
About this licence
Centralised EU authorisation. This product holds an EU-wide marketing authorisation granted by the European Commission after assessment by the European Medicines Agency, valid in every EU country. Its EU product number is 1097. It has been authorised for 10 years (since 26 May 2016). The HPRA list does not say whether it is on sale.
Other medicines with Autologous cd34+ enriched cell fraction in Ireland
No other product on the HPRA list contains Autologous cd34+ enriched cell fraction.
The licence holder
Fondazione Telethon Ets holds 2 products on the HPRA list, with 2 different active substances; 0 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 19 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.